KAPPA BIOSCIENCE
Kappa Bioscience is the pioneer in the development and production of the only synthetic and biologically active all-trans menaquinone-7 (vitamin K2 MK-7), marketed under the K2VITAL brand name. Kappaโs innovation of MK-7 synthesis marks the commercial milestone where this fat-soluble vitamin can begin to attain widespread consumer adoption. Effective synthesis production drives scalability, price reduction, and a secure supply chain - with unmatched ingredient purity and documentation. Combine... d with other Kappa innovations such as the patented DELTA microencapsulation process, which provides K2 stability in mineral formulations, K2VITAL offers brands and manufacturers a path to broader market segments. Kappa Ingredients GmbH, a wholly-owned division of Kappa Bioscience, manages global sales of the K2VITAL and other product lines directly and through a network of global distributors. Kappa Ingredients GmbH, a wholly-owned division of Kappa Bioscience, manages global sales of the K2VITAL and other product lines - Ingredients and services related to Bones, Joints, and Cardiovascular Health - directly and through a network of global distributors. The main products are Vitamin K2 - K2VITAL, Calcified Atlantic Seaweed, and The Bone Health Triangle.
KAPPA BIOSCIENCE
Industry:
Biotechnology Life Science Pharmaceutical Wellness
Founded:
2006-12-01
Address:
Oslo, Oslo, Norway
Country:
Norway
Website Url:
http://www.kappabio.com
Total Employee:
11+
Status:
Active
Contact:
+49 40 6094087 0
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Euro IPv6 Apple Mobile Web App Capable Pound Sterling Japanese Yen
Similar Organizations
Signum Biosciences
Signum Biosciences develops small molecule therapeutics derived from its STM platform to modulate signal transduction imbalances.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2017-01-24 | ppm.Ingredients | ppm.Ingredients acquired by Kappa Bioscience | N/A |
Investors List
SPRINGfondet
SPRINGfondet investment in Venture Round - Kappa Bioscience
Kistefos Venture Capital
Kistefos Venture Capital investment in Venture Round - Kappa Bioscience
Official Site Inspections
http://www.kappabio.com Semrush global rank: 4.48 M Semrush visits lastest month: 2.42 K
- Host name: dd28812.kasserver.com
- IP address: 85.13.147.64
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin